Ed in E. Coli and purified as described [3].Results The Light

Ed in E. Coli and purified as described [3].Results The Light Chains of MAP1B and MAP1A Eliglustat Interact with a1syntrophinThe COOH-terminal domain of MAP1 proteins is conserved in all members of this protein family from drosophila to man. To identify proteins interacting with this conserved domain which is located in the light chains of mammalian MAP1A, MAP1B and MAP1S, we performed a yeast 2-hybrid screen using this domain of LC1 as bait and a mouse 19-day embryo cDNA library as target. One of the candidate proteins identified in this screen was a1-syntrophin, a modular adapter protein with multiple protein interaction motifs associated with the dystrophin protein family [15?8]. We first confirmed that the light chains of MAP1B and MAP1A directly interact with a1-syntrophin. Purified recombinant a1syntrophin bound specifically to LC1 in a microtiter plate overlay assay (Fig. 1b). Likewise, in a blot overlay assay, recombinant a1syntrophin bound to LC1, LC2, and the conserved COOHterminal domain which was used as bait in the original screen (Fig. 1c). In contrast, a1-syntrophin did not interact with the NH2terminal domain of MAP1B (Fig. 1c). This 508-amino acid domain is also conserved in all proteins of the MAP1 family and was used here as negative control. To identify which domain(s) of a1-syntrophin interact with LC1 we first performed a yeast 2-hybrid b-galactosidase assay. Starting with the a1-syntrophin cDNA fragment that interacted with LC1 in the original screen and contained the PH1b, PH2, and SU 194423-15-9 site domains we analyzed the interaction with LC1 of several a1syntrophin deletion mutants. We found that the COOH terminus of LC1 (the bait protein of the screen) interacted with all a1syntrophin deletion mutants that contained the PH2 domain (Fig. 1d), revealing that this domain contains an LC1 binding site. This interaction of LC1 with the PH2 domain was confirmed in blot overlay assays (Fig. 1e). Since a1-syntrophin also contains a PDZ domain and LC1 and LC2 have been reported to interactProtein Interaction Assay with Europium Labeled ProteinsEuropium labeling of recombinant a-syntrophin and binding assays were performed as described previously [38]. Briefly, 96well microtiter plates were coated with 100 nM LC1 or BSA type H1 (Gerbu, Gaiberg, Germany) as a control. Following blocking with 4 BSA, plates were overlaid with increasing amounts of Eu3+-labeled a1-syntrophin. Plates were washed and protein bound was determined by releasing the complexed Eu3+ with enhancement solution and measuring fluorescence with a Delfia time-resolved fluorometer (Wallac, Turku, 1407003 Finland). Binding of asyntrophin to BSA was considered to be non-specific. For blot overlay assays, recombinant proteins were fractionated by SDS AGE. Blots (nitrocellulose membrane, 0.2 mm; Schleicher Schuell, Dassel, Germany) were blocked in buffer A (0.25 Tween 20 in phosphate-buffered saline) containing 2 bovine serum albumin (BSA) for 1 h, washed 3 times for 5 min in buffer A, incubated with 10?00 mg/ml recombinant protein in buffer A containing 2 BSA for 2 h, washed again, and probed with an appropriate primary antibody against the recombinant protein in buffer A containing 1 BSA. After additional washing, the recombinant protein-antibody complexes were detected using alkaline phosphatase-conjugated secondary antibodies (Promega, Mannheim, Germany) and a detection system described previously [39] or horse radish peroxidase-conjugated secondary antibodies (Jackson, West Grove,.Ed in E. Coli and purified as described [3].Results The Light Chains of MAP1B and MAP1A Interact with a1syntrophinThe COOH-terminal domain of MAP1 proteins is conserved in all members of this protein family from drosophila to man. To identify proteins interacting with this conserved domain which is located in the light chains of mammalian MAP1A, MAP1B and MAP1S, we performed a yeast 2-hybrid screen using this domain of LC1 as bait and a mouse 19-day embryo cDNA library as target. One of the candidate proteins identified in this screen was a1-syntrophin, a modular adapter protein with multiple protein interaction motifs associated with the dystrophin protein family [15?8]. We first confirmed that the light chains of MAP1B and MAP1A directly interact with a1-syntrophin. Purified recombinant a1syntrophin bound specifically to LC1 in a microtiter plate overlay assay (Fig. 1b). Likewise, in a blot overlay assay, recombinant a1syntrophin bound to LC1, LC2, and the conserved COOHterminal domain which was used as bait in the original screen (Fig. 1c). In contrast, a1-syntrophin did not interact with the NH2terminal domain of MAP1B (Fig. 1c). This 508-amino acid domain is also conserved in all proteins of the MAP1 family and was used here as negative control. To identify which domain(s) of a1-syntrophin interact with LC1 we first performed a yeast 2-hybrid b-galactosidase assay. Starting with the a1-syntrophin cDNA fragment that interacted with LC1 in the original screen and contained the PH1b, PH2, and SU domains we analyzed the interaction with LC1 of several a1syntrophin deletion mutants. We found that the COOH terminus of LC1 (the bait protein of the screen) interacted with all a1syntrophin deletion mutants that contained the PH2 domain (Fig. 1d), revealing that this domain contains an LC1 binding site. This interaction of LC1 with the PH2 domain was confirmed in blot overlay assays (Fig. 1e). Since a1-syntrophin also contains a PDZ domain and LC1 and LC2 have been reported to interactProtein Interaction Assay with Europium Labeled ProteinsEuropium labeling of recombinant a-syntrophin and binding assays were performed as described previously [38]. Briefly, 96well microtiter plates were coated with 100 nM LC1 or BSA type H1 (Gerbu, Gaiberg, Germany) as a control. Following blocking with 4 BSA, plates were overlaid with increasing amounts of Eu3+-labeled a1-syntrophin. Plates were washed and protein bound was determined by releasing the complexed Eu3+ with enhancement solution and measuring fluorescence with a Delfia time-resolved fluorometer (Wallac, Turku, 1407003 Finland). Binding of asyntrophin to BSA was considered to be non-specific. For blot overlay assays, recombinant proteins were fractionated by SDS AGE. Blots (nitrocellulose membrane, 0.2 mm; Schleicher Schuell, Dassel, Germany) were blocked in buffer A (0.25 Tween 20 in phosphate-buffered saline) containing 2 bovine serum albumin (BSA) for 1 h, washed 3 times for 5 min in buffer A, incubated with 10?00 mg/ml recombinant protein in buffer A containing 2 BSA for 2 h, washed again, and probed with an appropriate primary antibody against the recombinant protein in buffer A containing 1 BSA. After additional washing, the recombinant protein-antibody complexes were detected using alkaline phosphatase-conjugated secondary antibodies (Promega, Mannheim, Germany) and a detection system described previously [39] or horse radish peroxidase-conjugated secondary antibodies (Jackson, West Grove,.